🇺🇸 FDA
Company

Apogee

Apogee Therapeutics

APGE biotech USA

Quick answer

Apogee is a biotech company (APGE) headquartered in WALTHAM, MA, USA with 6 tracked pipeline programs.

Pipeline (6)

project

ABC294640

Carcinoma, Hepatocellular

Phase 2 · small_molecule · terminated

1 trials project

ABC294640

Diffuse Large B Cell Lymphoma

Phase 2 · small_molecule · terminated

1 trials project

APG777

Atopic Dermatitis

Phase 2 · small_molecule · active

3 trials project

Opaganib

Multiple Myeloma

Phase 2 · small_molecule · terminated

1 trials project

APG777

Asthma

Phase 1 · small_molecule · active

1 trials project

sphingosine kinase-2 inhibitor ABC294640

Pancreatic Cancer

Phase 1 · small_molecule · completed

1 trials

Patents (7)

patent

US 12410137

Fatty acid amide hydrolase modulators, compositions comprising the same and uses

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12378231

Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and u

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12358979

Antibodies that bind interleukin 13 and methods of use

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8685936

Sphingosine kinase inhibitor prodrugs

Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8557800

Sphingosine kinase inhibitors

Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8063248

Sphingosine kinase inhibitors

Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7338961

Sphingosine kinase inhibitors

Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)